Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Late-breaking clinical trials at TCT 2023 could lead to FDA approvals for Abbott, Boston Scientific

TCT 2023 late-breaking clinical trials

Will a coronary drug-coated balloon finally gain full approval from the FDA? New data presented at TCT 2023 seems to suggest it just might happen.  

  • Read more about Late-breaking clinical trials at TCT 2023 could lead to FDA approvals for Abbott, Boston Scientific

PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

TCT 2023 San Francisco

All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

  • Read more about PARTNER 3, Evolut and more: TAVR takes the spotlight in 4 late-breaking clinical trials at TCT 2023

FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

Medtronic extravascular ICD Aurora EV-ICD MRI SureScan

Aurora EV-ICD image courtesy of Medtronic.

The Aurora EV-ICD MRI SureScan is similar in size and shape to traditional ICDs, but it is implanted outside of the patient’s heart and veins.

  • Read more about FDA approves Medtronic’s extravascular ICD for abnormal heart rhythms

ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

Ziad Ali, MD, explains the ILUMIEN IV trial results for OCT Vs. Angiography.

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

  • Read more about ILUMIEN IV: OCT adds value over angiography alone, fails to improve outcomes

The evolving roles of TEE and ICE in structural heart interventions

Akhil Narang, MD, director of the echocardiography laboratory at Northwestern Medicine explains the latest trends in structural heart interventional imaging. #ASE #ASE23 #ASE2023 #structuralheart #echofirst

Akhil Narang, MD, explained that the two technologies can be used together to deliver high-quality patient care. 

  • Read more about The evolving roles of TEE and ICE in structural heart interventions

AI detects signs of AFib in asymptomatic patients

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

The study included ECG data from more than 900,000 U.S. veterans.

  • Read more about AI detects signs of AFib in asymptomatic patients

Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023

Shockwave Medical C2+ catheter TCT 2023 announcement

Image courtesy of Shockwave Medical.

According to Shockwave, the updated IVL catheter can deliver 50% more pulses than its previous offering. 

  • Read more about Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023

ICE Catheters: Improving Care for 2 million+ Patients

ICE Catheters: Improving Care for 2 million+ Patients

Four leading physicians in intracardiac echocardiography talk about the milestones achieved with ACUSON AcuNav 2D and 4D intracardiac echo catheters over the last 24 years.

  • Read more about ICE Catheters: Improving Care for 2 million+ Patients

Heart-healthy diets may help women limit signs of cognitive decline later in life

In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.

More than 5,000 women were interviewed about their eating habits from 1985 to 1991, and then researchers followed up with them 30 years later. The full study was published in Alzheimer’s and Dementia.

  • Read more about Heart-healthy diets may help women limit signs of cognitive decline later in life

Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

surgery.jpg

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

  • Read more about Radial access shows potential to ‘revolutionize’ care for peripheral artery disease

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …268
    • Page 269
    • Page 270
    • Page 271
    • Current page 272
    • Page 273
    • Page 274
    • Page 275
    • Page 276 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme